Hepatocellular carcinoma (HCC) biomarkers in Colombia

Authors

  • María Cristina Navas Universidad de Antioquia

DOI:

https://doi.org/10.17533/udea.iatreia.4359

Abstract

The hepatocellular carcinoma (HCC) account for 70 to 85% of primary liver cancer worldwide. SouthEast Asia and sub-Saharan Africa represent the areas with the highest incidence; instead Europe and North America correspond to low incidence areas. The data available for Latin American countries show a low incidence (<3.3/100.000 inhabitants) in most of the countries including Colombia. The rate of incidence is <5.6/100.000 in Central America, Peru and Argentina and <10/100.000 in Chile and Brazil.

|Abstract
= 54 veces | PDF (ESPAÑOL (ESPAÑA))
= 22 veces|

Downloads

Download data is not yet available.

Author Biography

María Cristina Navas, Universidad de Antioquia

Associate Professor, Grupo de Gastrohepatología, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad deAntioquia, Medellín, Colombia.

Downloads

Published

2007-02-08

How to Cite

1.
Navas MC. Hepatocellular carcinoma (HCC) biomarkers in Colombia. Iatreia [Internet]. 2007 Feb. 8 [cited 2025 Feb. 8];20(2-S):S-24. Available from: https://revistas.udea.edu.co/index.php/iatreia/article/view/4359

Issue

Vol. 20 No. 2-S

Section

Abstracts

License

Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.

The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)